Skip to main content
Ronald Gress, MD, Oncology, Bethesda, MD

Ronald Eugene Gress MD


Chief, Experimental Transplantation and Immunology Branch, CCR, NCI, NIH

Join to view full profile
  • 10 Crc3 3330NihBethesda, MD 20892

  • Phone+1 301-496-1791

Dr. Gress is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Baylor College of Medicine
    Baylor College of MedicineClass of 1975

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 1978 - 2024
  • TX State Medical License
    TX State Medical License 1975 - 1999
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 1991
  • Whos Who in Medicine and Healthcare Marquis Whos Who

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Impact of the 2014 NIH Chronic Graft-Versus-Host Disease Scoring Criteria Modifications Assessed in a Large Cohort of Severely Affected Patients  
    Lauren M Curtis, Galen O Joe, Jacqueline W Mays, Ann Berger, Pamela Stratton, Ronald E Gress, Sandra A Mitchell, Steven Z Pavletic, Kristin Baird, Nature

Abstracts/Posters

  • T Cells Expressing an Anti-B-Cell Maturation Antigen (BCMA) Chimeric Antigen Receptor with a Fully-Human Heavy-Chain-Only Antigen Recognition Domain Induce Remissions ...
    Ronald E. Gress, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Grant Support

  • Preclinical evaluation of a homing endonuclease gene therapy for adRP in models of P23H retinopathy.UNIVERSITY OF LOUISVILLE2023–2028
  • Neurexin Isoforms in Retina Structure and FunctionUNIVERSITY OF LOUISVILLE2025–2027
  • Glycine subunit specific inhibition and ganglion cell visual responsesUNIVERSITY OF LOUISVILLE2019–2025
  • Etib Clinical TrialsNational Cancer Institute2011
  • Etib Clinical Research CoreNational Cancer Institute2011

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: